| 1. Kym PR, Carlson KE, Katzenellenbogen JA.. (1993) Progestin 16 alpha, 17 alpha-dioxolane ketals as molecular probes for the progesterone receptor: synthesis, binding affinity, and photochemical evaluation., 36 (9): [PMID:8387596] [10.1021/jm00061a001] |
| 2. Dunn WJ, Koehler MG, Grigoras S.. (1987) The role of solvent-accessible surface area in determining partition coefficients., 30 (7): [PMID:3599019] [10.1021/jm00390a002] |
| 3. Kochanny MJ, VanBrocklin HF, Kym PR, Carlson KE, O'Neil JP, Bonasera TA, Welch MJ, Katzenellenbogen JA.. (1993) Fluorine-18-labeled progestin ketals: synthesis and target tissue uptake selectivity of potential imaging agents for receptor-positive breast tumors., 36 (9): [PMID:8487253] [10.1021/jm00061a002] |
| 4. DeVries VG, Schaffer SA, Largis EE, Dutia MD, Wang CH, Bloom JD, Katocs AS.. (1986) Potential antiatherosclerotic agents. 5. An acyl-CoA:cholesterol O-acyltransferase inhibitor with hypocholesterolemic activity., 29 (7): [PMID:3100794] [10.1021/jm00157a002] |
| 5. Pillai KM, Murray WV, Shooshani I, Williams DL, Gordon D, Wang SY, Johnson F.. (1984) Steroids. 2. Synthesis of C-18 functionalized steroids via the Smith-Hughes route., 27 (9): [PMID:6471068] [10.1021/jm00375a008] |
| 6. Jorgensen WL, Duffy EM.. (2000) Prediction of drug solubility from Monte Carlo simulations., 10 (11): [PMID:10866370] [10.1016/s0960-894x(00)00172-4] |
| 7. Ojasoo T, Doré JC, Gilbert J, Raynaud JP.. (1988) Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis., 31 (6): [PMID:2897467] [10.1021/jm00401a015] |
| 8. Hoyte RM, Borderon K, Bryson K, Allen R, Hochberg RB, Brown TJ.. (1994) Synthesis and evaluation of 7 alpha-iodo-5 alpha-dihydrotestosterone as a potential radioligand for androgen receptor., 37 (8): [PMID:8164266] [10.1021/jm00034a022] |
| 9. Zhang P, Terefenko EA, Fensome A, Wrobel J, Winneker R, Zhang Z.. (2003) Novel 6-aryl-1,4-dihydrobenzo[d]oxazine-2-thiones as potent, selective, and orally active nonsteroidal progesterone receptor agonists., 13 (7): [PMID:12657271] [10.1016/s0960-894x(03)00128-8] |
| 10. Surcouf E, Lepicard G, Mornon JP, Ojasoo T, Raynaud JP.. (1983) Additional conformational data for the mapping of the progestin binding site: crystal structures of 21-(phenylseleno)progesterone and 17 alpha-(phenylseleno)progesterone., 26 (9): [PMID:6887208] [10.1021/jm00363a019] |
| 11. Azzaoui K, Diaz-Perez MJ, Zannis-Hadjoupoulos M, Price GB, Wainer IW.. (1998) Effect of steroids on DNA synthesis in an in vitro replication system: initial quantitative structure-activity relationship studies and construction of a non-estrogen receptor pharmacophore., 41 (9): [PMID:9554872] [10.1021/jm970725m] |
| 12. Stiefl N, Baumann K.. (2003) Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique., 46 (8): [PMID:12672239] [10.1021/jm021077w] |
| 13. Zhi L, Tegley CM, Marschke KB, Mais DE, Jones TK.. (1999) 5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a novel class of nonsteroidal progesterone receptor agonists: effect of A-ring modification., 42 (8): [PMID:10212133] [10.1021/jm980723h] |
| 14. Purdy RH, Morrow AL, Blinn JR, Paul SM.. (1990) Synthesis, metabolism, and pharmacological activity of 3 alpha-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes., 33 (6): [PMID:2160534] [10.1021/jm00168a008] |
| 15. Andrews PR, Craik DJ, Martin JL.. (1984) Functional group contributions to drug-receptor interactions., 27 (12): [PMID:6094812] [10.1021/jm00378a021] |
| 16. Kamata S, Matsui T, Haga N, Nakamura M, Odaguchi K, Itoh T, Shimizu T, Suzuki T, Ishibashi M, Yamada F.. (1987) Aldosterone antagonists. 2. Synthesis and biological activities of 11,12-dehydropregnane derivatives., 30 (9): [PMID:3040999] [10.1021/jm00392a022] |
| 17. Hoyte RM, Rosner W, Johnson IS, Zielinski J, Hochberg RB.. (1985) Synthesis and evaluation of potential radioligands for the progesterone receptor., 28 (11): [PMID:4067997] [10.1021/jm00149a027] |
| 18. Suomalainen P, Johans C, Söderlund T, Kinnunen PK.. (2004) Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability., 47 (7): [PMID:15027870] [10.1021/jm0309001] |
| 19. Hamann LG, Farmer LJ, Johnson MG, Bender SL, Mais DE, Wang MW, Crombie D, Goldman ME, Jones TK.. (1996) Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl ether., 39 (9): [PMID:8627601] [10.1021/jm950747d] |
| 20. Zhi L, Tegley CM, Pio B, Edwards JP, Jones TK, Marschke KB, Mais DE, Risek B, Schrader WT.. (2003) Synthesis and biological activity of 5-methylidene 1,2-dihydrochromeno[3,4-f]quinoline derivatives as progesterone receptor modulators., 13 (12): [PMID:12781197] [10.1016/s0960-894x(03)00255-5] |
| 21. Silverman BD, Platt DE.. (1996) Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition., 39 (11): [PMID:8667357] [10.1021/jm950589q] |
| 22. Collins MA, Hudak V, Bender R, Fensome A, Zhang P, Miller L, Winneker RC, Zhang Z, Zhu Y, Cohen J, Unwalla RJ, Wrobel J.. (2004) Novel pyrrole-containing progesterone receptor modulators., 14 (9): [PMID:15081005] [10.1016/j.bmcl.2004.02.054] |
| 23. Crivori P, Cruciani G, Carrupt PA, Testa B.. (2000) Predicting blood-brain barrier permeation from three-dimensional molecular structure., 43 (11): [PMID:10841799] [10.1021/jm990968+] |
| 24. Jain AN, Koile K, Chapman D.. (1994) Compass: predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmark., 37 (15): [PMID:8057280] [10.1021/jm00041a010] |
| 25. Jarman M, Barrie SE, Deadman JJ, Houghton J, McCague R, Rowlands MG.. (1990) Hydroxyperfluoroazobenzenes: novel inhibitors of enzymes of androgen biosynthesis., 33 (9): [PMID:2391687] [10.1021/jm00171a019] |
| 26. Kubinyi H, Hamprecht FA, Mietzner T.. (1998) Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices., 41 (14): [PMID:9651159] [10.1021/jm970732a] |
| 27. Yoshida F, Topliss JG.. (2000) QSAR model for drug human oral bioavailability., 43 (13): [PMID:10891117] [10.1021/jm0000564] |
| 28. Kotani T, Higashiura K.. (2004) Comparative molecular active site analysis (CoMASA). 1. An approach to rapid evaluation of 3D QSAR., 47 (11): [PMID:15139751] [10.1021/jm030364c] |
| 29. Edwards JP, Zhi L, Pooley CL, Tegley CM, West SJ, Wang MW, Gottardis MM, Pathirana C, Schrader WT, Jones TK.. (1998) Preparation, resolution, and biological evaluation of 5-aryl-1, 2-dihydro-5H-chromeno[3,4-f]quinolines: potent, orally active, nonsteroidal progesterone receptor agonists., 41 (15): [PMID:9667968] [10.1021/jm980190c] |
| 30. Davioud E, Fagart J, Souque A, Rafestin-Oblin ME, Marquet A.. (1996) New steroidal diazo ketones as potential photoaffinity labeling reagents for the mineralocorticoid receptor: synthesis and biological activities., 39 (14): [PMID:8709117] [10.1021/jm9601359] |
| 31. Good AC, Peterson SJ, Richards WG.. (1993) QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods., 36 (20): [PMID:8411009] [10.1021/jm00072a012] |
| 32. Zhi L, Tegley CM, Kallel EA, Marschke KB, Mais DE, Gottardis MM, Jones TK.. (1998) 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists., 41 (3): [PMID:9464360] [10.1021/jm9705768] |
| 33. Edwards JP, West SJ, Marschke KB, Mais DE, Gottardis MM, Jones TK.. (1998) 5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents., 41 (3): [PMID:9464361] [10.1021/jm9705770] |
| 34. Crippen GM.. (1997) Validation of EGSITE2, a mixed integer program for deducing objective site models for experimental binding data., 40 (20): [PMID:9379435] [10.1021/jm970211n] |
| 35. Pastor M, Cruciani G, McLay I, Pickett S, Clementi S.. (2000) GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors., 43 (17): [PMID:10966742] [10.1021/jm000941m] |
| 36. Farr CD, Tabet MR, Ball WJ, Fishwild DM, Wang X, Nair AC, Welsh WJ.. (2002) Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis., 45 (15): [PMID:12109909] [10.1021/jm0102811] |
| 37. Buckman BO, Bonasera TA, Kirschbaum KS, Welch MJ, Katzenellenbogen JA.. (1995) Fluorine-18-labeled progestin 16 alpha, 17 alpha-dioxolanes: development of high-affinity ligands for the progesterone receptor with high in vivo target site selectivity., 38 (2): [PMID:7830275] [10.1021/jm00002a014] |
| 38. Zhi L, Tegley CM, Edwards JP, West SJ, Marschke KB, Gottardis MM, Mais DE, Jones TK.. (1998) 5-Alkyl 1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal progesterone receptor modulators., 8 (23): [PMID:9873735] [10.1016/s0960-894x(98)00608-8] |
| 39. Bohl CE, Chang C, Mohler ML, Chen J, Miller DD, Swaan PW, Dalton JT.. (2004) A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor., 47 (15): [PMID:15239655] [10.1021/jm0499007] |
| 40. Leonessa F, Kim JH, Ghiorghis A, Kulawiec RJ, Hammer C, Talebian A, Clarke R.. (2002) C-7 analogues of progesterone as potent inhibitors of the P-glycoprotein efflux pump., 45 (2): [PMID:11784143] [10.1021/jm010126m] |
| 41. Zhi L, Tegley CM, Pio B, Edwards JP, Motamedi M, Jones TK, Marschke KB, Mais DE, Risek B, Schrader WT.. (2003) 5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators., 46 (19): [PMID:12954062] [10.1021/jm020477g] |
| 42. Zhi L, Tegley CM, Pio B, West SJ, Marschke KB, Mais DE, Jones TK.. (2000) Nonsteroidal progesterone receptor antagonists based on 6-thiophenehydroquinolines., 10 (5): [PMID:10743938] [10.1016/s0960-894x(00)00011-1] |
| 43. So SS, Karplus M.. (1997) Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 1. Method and validations., 40 (26): [PMID:9435904] [10.1021/jm970487v] |
| 44. Tegley CM, Zhi L, Marschke KB, Gottardis MM, Yang Q, Jones TK.. (1998) 5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists., 41 (22): [PMID:9784110] [10.1021/jm980366a] |
| 45. Colmenarejo G, Alvarez-Pedraglio A, Lavandera JL.. (2001) Cheminformatic models to predict binding affinities to human serum albumin., 44 (25): [PMID:11728183] [10.1021/jm010960b] |
| 46. Good AC, So SS, Richards WG.. (1993) Structure-activity relationships from molecular similarity matrices., 36 (4): [PMID:8474098] [10.1021/jm00056a002] |
| 47. Jyrkkärinne J, Mäkinen J, Gynther J, Savolainen H, Poso A, Honkakoski P.. (2003) Molecular determinants of steroid inhibition for the mouse constitutive androstane receptor., 46 (22): [PMID:14561088] [10.1021/jm030861t] |
| 48. Lombardo F, Blake JF, Curatolo WJ.. (1996) Computation of brain-blood partitioning of organic solutes via free energy calculations., 39 (24): [PMID:8941388] [10.1021/jm960163r] |
| 49. Combs DW, Reese K, Phillips A.. (1995) Nonsteroidal progesterone receptor ligands. 1. 3-Aryl-1-benzoyl-1,4,5,6-tetrahydropyridazines., 38 (25): [PMID:8523399] [10.1021/jm00025a003] |
| 50. Combs DW, Reese K, Cornelius LA, Gunnet JW, Cryan EV, Granger KS, Jordan JJ, Demarest KT.. (1995) Nonsteroidal progesterone receptor ligands. 2. High-affinity ligands with selectivity for bone cell progesterone receptors., 38 (25): [PMID:8523400] [10.1021/jm00025a004] |
| 51. Zhang P, Terefenko EA, Fensome A, Zhang Z, Zhu Y, Cohen J, Winneker R, Wrobel J, Yardley J.. (2002) Potent nonsteroidal progesterone receptor agonists: synthesis and SAR study of 6-aryl benzoxazines., 12 (5): [PMID:11859003] [10.1016/s0960-894x(02)00025-2] |
| 52. Afzelius L, Zamora I, Masimirembwa CM, Karlén A, Andersson TB, Mecucci S, Baroni M, Cruciani G.. (2004) Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors., 47 (4): [PMID:14761192] [10.1021/jm030972s] |
| 53. Wohnsland F, Faller B.. (2001) High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes., 44 (6): [PMID:11300874] [10.1021/jm001020e] |
| 54. Laggner C, Schieferer C, Fiechtner B, Poles G, Hoffmann RD, Glossmann H, Langer T, Moebius FF.. (2005) Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening., 48 (15): [PMID:16033255] [10.1021/jm049073+] |
| 55. Caron G, Ermondi G.. (2005) Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk)., 48 (9): [PMID:15857133] [10.1021/jm048980b] |
| 56. Zhao L, Brinton RD.. (2005) Structure-based virtual screening for plant-based ERbeta-selective ligands as potential preventative therapy against age-related neurodegenerative diseases., 48 (10): [PMID:15887952] [10.1021/jm0490538] |
| 57. Lill MA, Winiger F, Vedani A, Ernst B.. (2005) Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals., 48 (18): [PMID:16134935] [10.1021/jm050403f] |
| 58. Ottaviani G, Martel S, Carrupt PA.. (2006) Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability., 49 (13): [PMID:16789751] [10.1021/jm060230+] |
| 59. Söderholm AA, Lehtovuori PT, Nyrönen TH.. (2006) Docking and three-dimensional quantitative structure-activity relationship (3D QSAR) analyses of nonsteroidal progesterone receptor ligands., 49 (14): [PMID:16821785] [10.1021/jm060234e] |
| 60. Zhang P, Terefenko E, Kern J, Fensome A, Trybulski E, Unwalla R, Wrobel J, Lockhead S, Zhu Y, Cohen J, Lacava M, Winneker RC, Zhang Z.. (2007) 5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist., 15 (20): [PMID:17681796] [10.1016/j.bmc.2007.07.011] |
| 61. Müller H, Klinkhammer W, Globisch C, Kassack MU, Pajeva IK, Wiese M.. (2007) New functional assay of P-glycoprotein activity using Hoechst 33342., 15 (23): [PMID:17890094] [10.1016/j.bmc.2007.07.024] |
| 62. Ottaviani G, Martel S, Carrupt PA.. (2007) In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities., 50 (4): [PMID:17300161] [10.1021/jm0611105] |
| 63. Baert B, Deconinck E, Van Gele M, Slodicka M, Stoppie P, Bodé S, Slegers G, Vander Heyden Y, Lambert J, Beetens J, De Spiegeleer B.. (2007) Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds., 15 (22): [PMID:17827020] [10.1016/j.bmc.2007.07.050] |
| 64. Cherkasov A, Ban F, Santos-Filho O, Thorsteinson N, Fallahi M, Hammond GL.. (2008) An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin., 51 (7): [PMID:18330978] [10.1021/jm7011485] |
| 65. Fong WF, Shen XL, Globisch C, Wiese M, Chen GY, Zhu GY, Yu ZL, Tse AK, Hu YJ.. (2008) Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells., 16 (7): [PMID:18313307] [10.1016/j.bmc.2008.02.029] |
| 66. Ekins S, Mankowski DC, Hoover DJ, Lawton MP, Treadway JL, Harwood HJ.. (2007) Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors., 35 (3): [PMID:17194716] [10.1124/dmd.106.013888] |
| 67. Sato H, Macchiarulo A, Thomas C, Gioiello A, Une M, Hofmann AF, Saladin R, Schoonjans K, Pellicciari R, Auwerx J.. (2008) Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies., 51 (6): [PMID:18307294] [10.1021/jm7015864] |
| 68. Pedram B, van Oeveren A, Mais DE, Marschke KB, Verbost PM, Groen MB, Zhi L.. (2008) A tissue-selective nonsteroidal progesterone receptor modulator: 7,9-difluoro-5-(3-methylcyclohex-2-enyl)-2,2,4-trimethyl-1,2-dihydrochromeno[3,4-f]quinoline., 51 (13): [PMID:18553958] [10.1021/jm8004256] |
| 69. Chuang S, Velkov T, Horne J, Porter CJ, Scanlon MJ.. (2008) Characterization of the drug binding specificity of rat liver fatty acid binding protein., 51 (13): [PMID:18533710] [10.1021/jm701192w] |
| 70. Pick A, Müller H, Wiese M.. (2008) Structure-activity relationships of new inhibitors of breast cancer resistance protein (ABCG2)., 16 (17): [PMID:18678495] [10.1016/j.bmc.2008.07.034] |
| 71. Marco-Contelles J, León R, de los Ríos C, Samadi A, Bartolini M, Andrisano V, Huertas O, Barril X, Luque FJ, Rodríguez-Franco MI, López B, López MG, García AG, Carreiras Mdo C, Villarroya M.. (2009) Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease., 52 (9): [PMID:19374444] [10.1021/jm801292b] |
| 72. Ahlin G, Karlsson J, Pedersen JM, Gustavsson L, Larsson R, Matsson P, Norinder U, Bergström CA, Artursson P.. (2008) Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1., 51 (19): [PMID:18788725] [10.1021/jm8003152] |
| 73. Recio MC, Just MJ, Giner RM, Mañez S, Rios JL, Hostettmann K.. (1995) Anti-inflammatory activity of saikosaponins from Heteromorpha trifoliata., 58 (1): [PMID:7760072] [10.1021/np50115a023] |
| 74. Pedersen JM, Matsson P, Bergström CA, Norinder U, Hoogstraate J, Artursson P.. (2008) Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2)., 51 (11): [PMID:18457386] [10.1021/jm7015683] |
| 75. Kern JC, Terefenko EA, Fensome A, Unwalla R, Wrobel J, Cohen J, Zhu Y, Berrodin TJ, Yudt MR, Winneker RC, Zhang Z, Zhang P.. (2008) 1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5'-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators., 18 (18): [PMID:18722119] [10.1016/j.bmcl.2008.08.015] |
| 76. Singh P, Kaur J, Kaur P, Kaur S.. (2009) Search for MDR modulators: design, syntheses and evaluations of N-substituted acridones for interactions with p-glycoprotein and Mg2+., 17 (6): [PMID:19243953] [10.1016/j.bmc.2009.02.002] |
| 77. Camps P, Formosa X, Galdeano C, Muñoz-Torrero D, Ramírez L, Gómez E, Isambert N, Lavilla R, Badia A, Clos MV, Bartolini M, Mancini F, Andrisano V, Arce MP, Rodríguez-Franco MI, Huertas O, Dafni T, Luque FJ.. (2009) Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds., 52 (17): [PMID:19663388] [10.1021/jm900859q] |
| 78. Thompson SK, Washburn DG, Frazee JS, Madauss KP, Hoang TH, Lapinski L, Grygielko ET, Glace LE, Trizna W, Williams SP, Duraiswami C, Bray JD, Laping NJ.. (2009) Rational design of orally-active, pyrrolidine-based progesterone receptor partial agonists., 19 (16): [PMID:19595590] [10.1016/j.bmcl.2009.06.055] |
| 79. MacNevin CJ, Atif F, Sayeed I, Stein DG, Liotta DC.. (2009) Development and screening of water-soluble analogues of progesterone and allopregnanolone in models of brain injury., 52 (19): [PMID:19791804] [10.1021/jm900712n] |
| 80. Lee PH, Conradi R, Shanmugasundaram V.. (2010) Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay., 20 (1): [PMID:19963379] [10.1016/j.bmcl.2009.11.039] |
| 81. Du-Cuny L, Song Z, Moses S, Powis G, Mash EA, Meuillet EJ, Zhang S.. (2009) Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain., 17 (19): [PMID:19734051] [10.1016/j.bmc.2009.08.022] |
| 82. Arce MP, Rodríguez-Franco MI, González-Muñoz GC, Pérez C, López B, Villarroya M, López MG, García AG, Conde S.. (2009) Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease., 52 (22): [PMID:19856923] [10.1021/jm900628z] |
| 83. Roll DM, Barbieri LR, Bigelis R, McDonald LA, Arias DA, Chang LP, Singh MP, Luckman SW, Berrodin TJ, Yudt MR.. (2009) The lecanindoles, nonsteroidal progestins from the terrestrial fungus Verticillium lecanii 6144., 72 (11): [PMID:19863083] [10.1021/np9004882] |
| 84. Bellavance E, Luu-The V, Poirier D.. (2009) Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone., 52 (23): [PMID:19772289] [10.1021/jm900921c] |
| 85. Dexheimer TS, Gediya LK, Stephen AG, Weidlich I, Antony S, Marchand C, Interthal H, Nicklaus M, Fisher RJ, Njar VC, Pommier Y.. (2009) 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors., 52 (22): [PMID:19883083] [10.1021/jm901061s] |
| 86. Guerra A, Campillo NE, Páez JA.. (2010) Neural computational prediction of oral drug absorption based on CODES 2D descriptors., 45 (3): [PMID:20022146] [10.1016/j.ejmech.2009.11.034] |
| 87. Zeinyeh W, Alameh G, Radix S, Grenot C, Dumontet C, Walchshofer N.. (2010) Design, synthesis and evaluation of progesterone-adenine hybrids as bivalent inhibitors of P-glycoprotein-mediated multidrug efflux., 20 (10): [PMID:20399647] [10.1016/j.bmcl.2010.03.085] |
| 88. Singh P, Kaur J, Yadav B, Komath SS.. (2010) Targeting efflux pumps-In vitro investigations with acridone derivatives and identification of a lead molecule for MDR modulation., 18 (12): [PMID:20576574] [10.1016/j.bmc.2010.05.003] |
| 89. Du Y, Li Q, Xiong B, Hui X, Wang X, Feng Y, Meng T, Hu D, Zhang D, Wang M, Shen J.. (2010) Aromatic beta-amino-ketone derivatives as novel selective non-steroidal progesterone receptor antagonists., 18 (12): [PMID:20510622] [10.1016/j.bmc.2010.04.092] |
| 90. Zeinyeh W, Xia H, Lawton P, Radix S, Marminon C, Nebois P, Walchshofer N.. (2010) Synthesis and modulation properties of imidazo[4,5-b]pyridin-7-one and indazole-4,7-dione derivatives towards the Cryptosporidium parvum CpABC3 transporter., 45 (6): [PMID:20207054] [10.1016/j.ejmech.2010.02.033] |
| 91. Prado-Prado FJ, García-Mera X, González-Díaz H.. (2010) Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species., 18 (6): [PMID:20185316] [10.1016/j.bmc.2010.01.068] |
| 92. Young DW, Bender A, Hoyt J, McWhinnie E, Chirn GW, Tao CY, Tallarico JA, Labow M, Jenkins JL, Mitchison TJ, Feng Y.. (2008) Integrating high-content screening and ligand-target prediction to identify mechanism of action., 4 (1): [PMID:18066055] [10.1038/nchembio.2007.53] |
| 93. Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, Dirks PB.. (2007) Chemical genetics reveals a complex functional ground state of neural stem cells., 3 (5): [PMID:17417631] [10.1038/nchembio873] |
| 94. Yuan J, Johnson RL, Huang R, Wichterman J, Jiang H, Hayton K, Fidock DA, Wellems TE, Inglese J, Austin CP, Su XZ.. (2009) Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum., 5 (10): [PMID:19734910] [10.1038/nchembio.215] |
| 95. Puri N, Prakash O, Manoharlal R, Sharma M, Ghosh I, Prasad R.. (2010) Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans., 45 (11): [PMID:20739103] [10.1016/j.ejmech.2010.07.050] |
| 96. PubChem BioAssay data set, |
| 97. PubChem BioAssay data set, |
| 98. PubChem BioAssay data set, |
| 99. PubChem BioAssay data set, |
| 100. PubChem BioAssay data set, |
| 101. PubChem BioAssay data set, |
| 102. PubChem BioAssay data set, |
| 103. PubChem BioAssay data set, |
| 104. Miller CP, Shomali M, Lyttle CR, O'Dea LS, Herendeen H, Gallacher K, Paquin D, Compton DR, Sahoo B, Kerrigan SA, Burge MS, Nickels M, Green JL, Katzenellenbogen JA, Tchesnokov A, Hattersley G.. (2011) Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140., 2 (2): [PMID:24900290] [10.1021/ml1002508] |
| 105. Nagata N, Miyakawa M, Amano S, Furuya K, Yamamoto N, Inoguchi K.. (2011) Design and synthesis of tricyclic tetrahydroquinolines as a new series of nonsteroidal selective androgen receptor modulators (SARMs)., 21 (6): [PMID:21349712] [10.1016/j.bmcl.2011.01.073] |
| 106. Alvarez LD, Dansey MV, Martí MA, Bertucci PY, Di Chenna PH, Pecci A, Burton G.. (2011) Biological activity and ligand binding mode to the progesterone receptor of A-homo analogues of progesterone., 19 (5): [PMID:21315613] [10.1016/j.bmc.2011.01.033] |
| 107. Greene N, Fisk L, Naven RT, Note RR, Patel ML, Pelletier DJ.. (2010) Developing structure-activity relationships for the prediction of hepatotoxicity., 23 (7): [PMID:20553011] [10.1021/tx1000865] |
| 108. Ekins S, Williams AJ, Xu JJ.. (2010) A predictive ligand-based Bayesian model for human drug-induced liver injury., 38 (12): [PMID:20843939] [10.1124/dmd.110.035113] |
| 109. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1): [PMID:20014752] [10.1021/tx900326k] |
| 110. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1): [PMID:20014752] [10.1021/tx900326k] |
| 111. Unpublished dataset, |
| 112. PubChem BioAssay data set, |
| 113. Gozalbes R, Jacewicz M, Annand R, Tsaioun K, Pineda-Lucena A.. (2011) QSAR-based permeability model for drug-like compounds., 19 (8): [PMID:21458999] [10.1016/j.bmc.2011.03.011] |
| 114. Schläger T, Schepmann D, Lehmkuhl K, Holenz J, Vela JM, Buschmann H, Wünsch B.. (2011) Combination of two pharmacophoric systems: synthesis and pharmacological evaluation of spirocyclic pyranopyrazoles with high σ₁ receptor affinity., 54 (19): [PMID:21859078] [10.1021/jm200585k] |
| 115. PubChem BioAssay data set, |
| 116. PubChem BioAssay data set, |
| 117. Tukey RH, Strassburg CP.. (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease., 40 (1): [PMID:10836148] [10.1146/annurev.pharmtox.40.1.581] |
| 118. Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program. DrugMatrix in vitro pharmacology data, |
| 119. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.. (2011) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)., 7 (12): [PMID:22194678] [10.1371/journal.pcbi.1002310] |
| 120. Nagata N, Miyakawa M, Amano S, Furuya K, Yamamoto N, Nejishima H, Inoguchi K.. (2011) Tetrahydroquinolines as a novel series of nonsteroidal selective androgen receptor modulators: structural requirements for better physicochemical and biological properties., 21 (21): [PMID:21944856] [10.1016/j.bmcl.2011.08.118] |
| 121. González-Muñoz GC, Arce MP, López B, Pérez C, Romero A, del Barrio L, Martín-de-Saavedra MD, Egea J, León R, Villarroya M, López MG, García AG, Conde S, Rodríguez-Franco MI.. (2011) N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease., 46 (6): [PMID:21420206] [10.1016/j.ejmech.2011.03.003] |
| 122. PubChem BioAssay data set, |
| 123. Guthrie DB, Stein DG, Liotta DC, Lockwood MA, Sayeed I, Atif F, Arrendale RF, Reddy GP, Evers TJ, Marengo JR, Howard RB, Culver DG, Natchus MG.. (2012) Water-soluble progesterone analogues are effective, injectable treatments in animal models of traumatic brain injury., 3 (5): [PMID:24900479] [10.1021/ml200303r] |
| 124. Sakatis MZ, Reese MJ, Harrell AW, Taylor MA, Baines IA, Chen L, Bloomer JC, Yang EY, Ellens HM, Ambroso JL, Lovatt CA, Ayrton AD, Clarke SE.. (2012) Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., 25 (10): [PMID:22931300] [10.1021/tx300075j] |
| 125. Nagy H, Goda K, Fenyvesi F, Bacsó Z, Szilasi M, Kappelmayer J, Lustyik G, Cianfriglia M, Szabó G.. (2004) Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies., 315 (1): [PMID:14985103] [10.1016/j.bbrc.2004.01.156] |
| 126. Uhr M, Holsboer F, Müller MB.. (2002) Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins., 14 (1): [PMID:12213137] [10.1046/j.1365-2826.2002.00836.x] |
| 127. Lecureur V, Fardel O, Guillouzo A.. (1994) The antiprogestatin drug RU 486 potentiates doxorubicin cytotoxicity in multidrug resistant cells through inhibition of P-glycoprotein function., 355 (1): [PMID:7982498] [10.1016/0014-5793(94)01186-9] |
| 128. Borgnia MJ, Eytan GD, Assaraf YG.. (1996) Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity., 271 (1): [PMID:8621716] [10.1074/jbc.271.6.3163] |
| 129. Adachi Y, Suzuki H, Sugiyama Y.. (2001) Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein., 18 (1): [PMID:11785684] [10.1023/a:1013358126640] |
| 130. Payen L, Delugin L, Courtois A, Trinquart Y, Guillouzo A, Fardel O.. (1999) Reversal of MRP-mediated multidrug resistance in human lung cancer cells by the antiprogestatin drug RU486., 258 (1): [PMID:10329417] [10.1006/bbrc.1999.0671] |
| 131. Wang EJ, Casciano CN, Clement RP, Johnson WW.. (2003) Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites., 20 (1): [PMID:12739759] [10.1023/a:1023278211849] |
| 132. Romiti N, Tramonti G, Chieli E.. (2002) Influence of different chemicals on MDR-1 P-glycoprotein expression and activity in the HK-2 proximal tubular cell line., 183 (1): [PMID:12387747] [10.1006/taap.2002.9461] |
| 133. Yamazaki M, Neway WE, Ohe T, Chen I, Rowe JF, Hochman JH, Chiba M, Lin JH.. (2001) In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results., 296 (1): [PMID:11181899] |
| 134. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R.. (1992) Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone., 267 (1): [PMID:1360010] [10.1016/s0021-9258(18)35757-0] |
| 135. Kim WY, Benet LZ.. (2004) P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro., 21 (1): [PMID:15290871] [10.1023/b:pham.0000033017.52484.81] |
| 136. Leonessa F, Kim JH, Ghiorghis A, Kulawiec RJ, Hammer C, Talebian A, Clarke R.. (2002) C-7 analogues of progesterone as potent inhibitors of the P-glycoprotein efflux pump., 45 (2): [PMID:11784143] [10.1021/jm010126m] |
| 137. Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, Ganapathy V.. (1998) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain., 273 (1): [PMID:9830022] [10.1074/jbc.273.49.32776] |
| 138. Janvilisri T, Venter H, Shahi S, Reuter G, Balakrishnan L, van Veen HW.. (2003) Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis., 278 (1): [PMID:12668685] [10.1074/jbc.m301358200] |
| 139. Wang EJ, Casciano CN, Clement RP, Johnson WW.. (2001) Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors., 289 (1): [PMID:11716514] [10.1006/bbrc.2001.6000] |
| 140. Hayer-Zillgen M, Brüss M, Bönisch H.. (2002) Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3., 136 (1): [PMID:12110607] [10.1038/sj.bjp.0704785] |
| 141. Kim RB, Leake B, Cvetkovic M, Roden MM, Nadeau J, Walubo A, Wilkinson GR.. (1999) Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity., 291 (1): [PMID:10565843] |
| 142. Schroeder A, Eckhardt U, Stieger B, Tynes R, Schteingart CD, Hofmann AF, Meier PJ, Hagenbuch B.. (1998) Substrate specificity of the rat liver Na(+)-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells., 274 (1): [PMID:9486191] [10.1152/ajpgi.1998.274.2.g370] |
| 143. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
| 144. Karlgren M, Vildhede A, Norinder U, Wisniewski JR, Kimoto E, Lai Y, Haglund U, Artursson P.. (2012) Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions., 55 (10): [PMID:22541068] [10.1021/jm300212s] |
| 145. Tsai CJ, Liang JW, Lin HR.. (2012) Sesquiterpenoids from Atractylodes macrocephala act as farnesoid X receptor and progesterone receptor modulators., 22 (6): [PMID:22365756] [10.1016/j.bmcl.2012.01.048] |
| 146. PubChem BioAssay data set, |
| 147. Meyer C, Neue B, Schepmann D, Yanagisawa S, Yamaguchi J, Würthwein EU, Itami K, Wünsch B.. (2013) Improvement of σ1 receptor affinity by late-stage C-H-bond arylation of spirocyclic lactones., 21 (7): [PMID:23462714] [10.1016/j.bmc.2013.01.038] |
| 148. Fan NJ, Tang JJ, Li H, Li XJ, Luo B, Gao JM.. (2013) Synthesis and cytotoxic activity of some novel steroidal C-17 pyrazolinyl derivatives., 69 [PMID:24021891] [10.1016/j.ejmech.2013.08.016] |
| 149. De Bruyn T, van Westen GJ, Ijzerman AP, Stieger B, de Witte P, Augustijns PF, Annaert PP.. (2013) Structure-based identification of OATP1B1/3 inhibitors., 83 (6): [PMID:23571415] [10.1124/mol.112.084152] |
| 150. Sun Y, Chen J, Chen X, Huang L, Li X.. (2013) Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids., 21 (23): [PMID:24128814] [10.1016/j.bmc.2013.09.050] |
| 151. Di Pietro O, Viayna E, Vicente-García E, Bartolini M, Ramón R, Juárez-Jiménez J, Clos MV, Pérez B, Andrisano V, Luque FJ, Lavilla R, Muñoz-Torrero D.. (2014) 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies., 73 [PMID:24389509] [10.1016/j.ejmech.2013.12.008] |
| 152. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R.. (2004) [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs]., 28 (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2] |
| 153. PubChem BioAssay data set, |
| 154. PubChem BioAssay data set, |
| 155. Mach RH, Zeng C, Hawkins WG.. (2013) The σ2 receptor: a novel protein for the imaging and treatment of cancer., 56 (18): [PMID:23734634] [10.1021/jm301545c] |
| 156. Mateus A, Matsson P, Artursson P.. (2014) A high-throughput cell-based method to predict the unbound drug fraction in the brain., 57 (7): [PMID:24601604] [10.1021/jm401963n] |
| 157. Solo AJ, Kumar V, Alks V.. (1979) Structural requirements for progestational activity. Synthesis and properties of rac-8alpha,9beta,10alpha,14beta-progesterone., 22 (2): [PMID:423192] [10.1021/jm00188a004] |
| 158. Samant BR, Sweet F.. (1977) Synthesis of medroxyprogesterone bromoacetate for affinity labeling., 20 (6): [PMID:874959] [10.1021/jm00216a019] |
| 159. Bond FT, Weyler W, Brunner B, Stemke JE.. (1976) Synthesis and biological inactivity of some 4alpha,6-cyclo steroids., 19 (2): [PMID:1249805] [10.1021/jm00224a011] |
| 160. Lee DL, Kollman PA, Marsh FJ, Wolff ME.. (1977) Quantitative relationships between steroid structure and binding to putative progesterone receptors., 20 (9): [PMID:926114] [10.1021/jm00219a006] |
| 161. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds, [10.6019/CHEMBL3301361] |
| 162. Gege C, Schlüter T, Hoffmann T.. (2014) Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt., 24 (22): [PMID:25305688] [10.1016/j.bmcl.2014.09.053] |
| 163. Sola I, Artigas A, Taylor MC, Gbedema SY, Pérez B, Clos MV, Wright CW, Kelly JM, Muñoz-Torrero D.. (2014) Synthesis and antiprotozoal activity of oligomethylene- and p-phenylene-bis(methylene)-linked bis(+)-huprines., 24 (23): [PMID:25454267] [10.1016/j.bmcl.2014.10.025] |
| 164. Pérez-Areales FJ, Di Pietro O, Espargaró A, Vallverdú-Queralt A, Galdeano C, Ragusa IM, Viayna E, Guillou C, Clos MV, Pérez B, Sabaté R, Lamuela-Raventós RM, Luque FJ, Muñoz-Torrero D.. (2014) Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties., 22 (19): [PMID:25156301] [10.1016/j.bmc.2014.07.053] |
| 165. Huang L, Miao H, Sun Y, Meng F, Li X.. (2014) Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease., 87 [PMID:25282266] [10.1016/j.ejmech.2014.09.081] |
| 166. Lan JS, Xie SS, Li SY, Pan LF, Wang XB, Kong LY.. (2014) Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease., 22 (21): [PMID:25282654] [10.1016/j.bmc.2014.08.035] |
| 167. Di Pietro O, Pérez-Areales FJ, Juárez-Jiménez J, Espargaró A, Clos MV, Pérez B, Lavilla R, Sabaté R, Luque FJ, Muñoz-Torrero D.. (2014) Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies., 84 [PMID:25016233] [10.1016/j.ejmech.2014.07.021] |
| 168. Huang M, Xie SS, Jiang N, Lan JS, Kong LY, Wang XB.. (2015) Multifunctional coumarin derivatives: monoamine oxidase B (MAO-B) inhibition, anti-β-amyloid (Aβ) aggregation and metal chelation properties against Alzheimer's disease., 25 (3): [PMID:25542589] [10.1016/j.bmcl.2014.12.034] |
| 169. Więckowska A, Więckowski K, Bajda M, Brus B, Sałat K, Czerwińska P, Gobec S, Filipek B, Malawska B.. (2015) Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo., 23 (10): [PMID:25868744] [10.1016/j.bmc.2015.03.051] |
| 170. Guzior N, Bajda M, Rakoczy J, Brus B, Gobec S, Malawska B.. (2015) Isoindoline-1,3-dione derivatives targeting cholinesterases: design, synthesis and biological evaluation of potential anti-Alzheimer's agents., 23 (7): [PMID:25707322] [10.1016/j.bmc.2015.01.045] |
| 171. Xie SS, Lan JS, Wang XB, Jiang N, Dong G, Li ZR, Wang KD, Guo PP, Kong LY.. (2015) Multifunctional tacrine-trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties., 93 [PMID:25656088] [10.1016/j.ejmech.2015.01.058] |
| 172. de Ravel MR, Alameh G, Melikian M, Mahiout Z, Emptoz-Bonneton A, Matera EL, Lomberget T, Barret R, Rocheblave L, Walchshofer N, Beltran S, El Jawad L, Mappus E, Grenot C, Pugeat M, Dumontet C, Le Borgne M, Cuilleron CY.. (2015) Synthesis of new steroidal inhibitors of P-glycoprotein-mediated multidrug resistance and biological evaluation on K562/R7 erythroleukemia cells., 58 (4): [PMID:25634041] [10.1021/jm501676v] |
| 173. Xie SS, Wang X, Jiang N, Yu W, Wang KD, Lan JS, Li ZR, Kong LY.. (2015) Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease., 95 [PMID:25812965] [10.1016/j.ejmech.2015.03.040] |
| 174. Di Pietro O, Vicente-García E, Taylor MC, Berenguer D, Viayna E, Lanzoni A, Sola I, Sayago H, Riera C, Fisa R, Clos MV, Pérez B, Kelly JM, Lavilla R, Muñoz-Torrero D.. (2015) Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity., 105 [PMID:26479031] [10.1016/j.ejmech.2015.10.007] |
| 175. Korade Z, Kim HY, Tallman KA, Liu W, Koczok K, Balogh I, Xu L, Mirnics K, Porter NA.. (2016) The Effect of Small Molecules on Sterol Homeostasis: Measuring 7-Dehydrocholesterol in Dhcr7-Deficient Neuro2a Cells and Human Fibroblasts., 59 (3): [PMID:26789657] [10.1021/acs.jmedchem.5b01696] |
| 176. Pan W, Hu K, Bai P, Yu L, Ma Q, Li T, Zhang X, Chen C, Peng K, Liu W, Sang Z.. (2016) Design, synthesis and evaluation of novel ferulic acid-memoquin hybrids as potential multifunctional agents for the treatment of Alzheimer's disease., 26 (10): [PMID:27072909] [10.1016/j.bmcl.2016.03.086] |
| 177. Xu W, Wang X, Wang Z, Wu J, Li F, Wang J, Kong L. (2016) Synthesis and evaluation of donepezilferulic acid hybrids as multi-target-directed ligands against Alzheimer's disease, 7 (5): [10.1039/C6MD00053C] |
| 178. Wang J, Wang ZM, Li XM, Li F, Wu JJ, Kong LY, Wang XB.. (2016) Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin., 24 (18): [PMID:27460699] [10.1016/j.bmc.2016.07.025] |
| 179. WHO Anatomical Therapeutic Chemical Classification, |
| 180. British National Formulary (72nd edition), |
| 181. Sola I, Artigas A, Taylor MC, Pérez-Areales FJ, Viayna E, Clos MV, Pérez B, Wright CW, Kelly JM, Muñoz-Torrero D.. (2016) Synthesis and biological evaluation of N-cyanoalkyl-, N-aminoalkyl-, and N-guanidinoalkyl-substituted 4-aminoquinoline derivatives as potent, selective, brain permeable antitrypanosomal agents., 24 (21): [PMID:27591008] [10.1016/j.bmc.2016.08.036] |
| 182. Wang ZM, Cai P, Liu QH, Xu DQ, Yang XL, Wu JJ, Kong LY, Wang XB.. (2016) Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease., 123 [PMID:27484514] [10.1016/j.ejmech.2016.07.052] |
| 183. Košak U, Knez D, Coquelle N, Brus B, Pišlar A, Nachon F, Brazzolotto X, Kos J, Colletier JP, Gobec S.. (2017) N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents., 25 (2): [PMID:27908752] [10.1016/j.bmc.2016.11.032] |
| 184. Więckowska A, Kołaczkowski M, Bucki A, Godyń J, Marcinkowska M, Więckowski K, Zaręba P, Siwek A, Kazek G, Głuch-Lutwin M, Mierzejewski P, Bienkowski P, Sienkiewicz-Jarosz H, Knez D, Wichur T, Gobec S, Malawska B.. (2016) Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation., 124 [PMID:27560283] [10.1016/j.ejmech.2016.08.016] |
| 185. DrugMatrix, [10.6019/CHEMBL3885881] |
| 186. Elkamhawy A, Park JE, Hassan AHE, Ra H, Pae AN, Lee J, Park BG, Moon B, Park HM, Roh EJ.. (2017) Discovery of 1-(3-(benzyloxy)pyridin-2-yl)-3-(2-(piperazin-1-yl)ethyl)urea: A new modulator for amyloid beta-induced mitochondrial dysfunction., 128 [PMID:28152427] [10.1016/j.ejmech.2016.12.057] |
| 187. Aleo MD, Luo Y, Swiss R, Bonin PD, Potter DM, Will Y.. (2014) Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump., 60 (3): [PMID:24799086] [10.1002/hep.27206] |
| 188. Warner DJ, Chen H, Cantin LD, Kenna JG, Stahl S, Walker CL, Noeske T.. (2012) Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification., 40 (12): [PMID:22961681] [10.1124/dmd.112.047068] |
| 189. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015] |
| 190. Xia CL, Wang N, Guo QL, Liu ZQ, Wu JQ, Huang SL, Ou TM, Tan JH, Wang HG, Li D, Huang ZS.. (2017) Design, synthesis and evaluation of 2-arylethenyl-N-methylquinolinium derivatives as effective multifunctional agents for Alzheimer's disease treatment., 130 [PMID:28242549] [10.1016/j.ejmech.2017.02.042] |
| 191. Monjas L, Arce MP, León R, Egea J, Pérez C, Villarroya M, López MG, Gil C, Conde S, Rodríguez-Franco MI.. (2017) Enzymatic and solid-phase synthesis of new donepezil-based L- and d-glutamic acid derivatives and their pharmacological evaluation in models related to Alzheimer's disease and cerebral ischemia., 130 [PMID:28242552] [10.1016/j.ejmech.2017.02.034] |
| 192. Liu W, Wang H, Li X, Xu Y, Zhang J, Wang W, Gong Q, Qiu X, Zhu J, Mao F, Zhang H, Li J.. (2018) Design, synthesis and evaluation of vilazodone-tacrine hybrids as multitarget-directed ligands against depression with cognitive impairment., 26 (12): [PMID:29729987] [10.1016/j.bmc.2018.04.037] |
| 193. Xu YX, Wang H, Li XK, Dong SN, Liu WW, Gong Q, Wang TD, Tang Y, Zhu J, Li J, Zhang HY, Mao F.. (2018) Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease., 143 [PMID:29172081] [10.1016/j.ejmech.2017.08.025] |
| 194. Jiang N, Huang Q, Liu J, Liang N, Li Q, Li Q, Xie SS.. (2018) Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease., 146 [PMID:29407958] [10.1016/j.ejmech.2018.01.055] |
| 195. Kwak SH, Shin S, Lee JH, Shim JK, Kim M, Lee SD, Lee A, Bae J, Park JH, Abdelrahman A, Müller CE, Cho SK, Kang SG, Bae MA, Yang JY, Ko H, Goddard WA, Kim YC.. (2018) Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells., 151 [PMID:29649742] [10.1016/j.ejmech.2018.03.023] |
| 196. Lan JS, Ding Y, Liu Y, Kang P, Hou JW, Zhang XY, Xie SS, Zhang T.. (2017) Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease., 139 [PMID:28797883] [10.1016/j.ejmech.2017.07.055] |
| 197. Wang J, Cai P, Yang XL, Li F, Wu JJ, Kong LY, Wang XB.. (2017) Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease., 139 [PMID:28800459] [10.1016/j.ejmech.2017.07.077] |
| 198. Kumar D, Gupta SK, Ganeshpurkar A, Gutti G, Krishnamurthy S, Modi G, Singh SK.. (2018) Development of Piperazinediones as dual inhibitor for treatment of Alzheimer's disease., 150 [PMID:29524731] [10.1016/j.ejmech.2018.02.078] |
| 199. Hepnarova V, Korabecny J, Matouskova L, Jost P, Muckova L, Hrabinova M, Vykoukalova N, Kerhartova M, Kucera T, Dolezal R, Nepovimova E, Spilovska K, Mezeiova E, Pham NL, Jun D, Staud F, Kaping D, Kuca K, Soukup O.. (2018) The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease., 150 [PMID:29533874] [10.1016/j.ejmech.2018.02.083] |
| 200. Lee JH, Dean M, Austin JR, Burdette JE, Murphy BT.. (2018) Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling., 81 (9): [PMID:30199256] [10.1021/acs.jnatprod.8b00131] |
| 201. Nath C, Badavath VN, Thakur A, Ucar G, Acevedo O, Mohd Siddique MU, Jayaprakash V.. (2018) Curcumin-based pyrazoline analogues as selective inhibitors of human monoamine oxidase A., 9 (7): [PMID:30109004] [10.1039/C8MD00196K] |
| 202. Unpublished dataset, |
| 203. Franck Touret, Magali Gilles, Karine Barral, Antoine Nougairède, Etienne Decroly, Xavier de Lamballerie, Bruno Coutard. (2020) In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication, [10.1101/2020.04.03.023846] |
| 204. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek. (2020) Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection, [10.21203/rs.3.rs-23951/v1] |
| 205. David E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, Jiewei Xu, Kirsten Obernier, Kris M White, Matthew J O'Meara, Veronica V Rezelj, Jeffrey Z Guo, Danielle L Swaney, et al. (2020) A SARS-CoV-2 protein interaction map reveals targets for drug repurposing, [PMID:32353859] [10.1038/s41586-020-2286-9] |
| 206. Pérez-Areales FJ, Turcu AL, Barniol-Xicota M, Pont C, Pivetta D, Espargaró A, Bartolini M, De Simone A, Andrisano V, Pérez B, Sabate R, Sureda FX, Vázquez S, Muñoz-Torrero D.. (2019) A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors., 180 [PMID:31351393] [10.1016/j.ejmech.2019.07.051] |
| 207. Srivastava P, Tripathi PN, Sharma P, Rai SN, Singh SP, Srivastava RK, Shankar S, Shrivastava SK.. (2019) Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory., 163 [PMID:30503937] [10.1016/j.ejmech.2018.11.049] |
| 208. Yu J, Zhang L, Yan G, Zhou P, Cao C, Zhou F, Li X, Chen Y.. (2019) Discovery and biological evaluation of novel androgen receptor antagonist for castration-resistant prostate cancer., 171 [PMID:30925341] [10.1016/j.ejmech.2019.03.041] |
| 209. Srivastava P, Tripathi PN, Sharma P, Shrivastava SK.. (2019) Design, synthesis, and evaluation of novel N-(4-phenoxybenzyl)aniline derivatives targeting acetylcholinesterase, β-amyloid aggregation and oxidative stress to treat Alzheimer's disease., 27 (16): [PMID:31288978] [10.1016/j.bmc.2019.07.001] |
| 210. Mathew B, Baek SC, Grace Thomas Parambi D, Pil Lee J, Joy M, Annie Rilda PR, Randev RV, Nithyamol P, Vijayan V, Inasu ST, Mathew GE, Lohidakshan KK, Kumar Krishnan G, Kim H.. (2018) Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors., 9 (11): [PMID:30568755] [10.1039/C8MD00399H] |
| 211. Passeri D, Carotti A, Pittol JMR, Ciaccioli G, Pellicciari R, van Mil SWC, Gioiello A.. (2019) Dissecting the allosteric FXR modulation: a chemical biology approach using guggulsterone as a chemical tool., 10 (8): [PMID:31673308] [10.1039/C9MD00264B] |
| 212. Farag AK, Hassan AHE, Jeong H, Kwon Y, Choi JG, Oh MS, Park KD, Kim YK, Roh EJ.. (2019) First-in-class DAPK1/CSF1R dual inhibitors: Discovery of 3,5-dimethoxy-N-(4-(4-methoxyphenoxy)-2-((6-morpholinopyridin-3-yl)amino)pyrimidin-5-yl)benzamide as a potential anti-tauopathies agent., 162 [PMID:30445265] [10.1016/j.ejmech.2018.10.057] |
| 213. (2012) New steroid inhibitors of pgp for use for inhibiting multidrug resistance, |
| 214. Hu J, Pan T, An B, Li Z, Li X, Huang L.. (2019) Synthesis and evaluation of clioquinol-rolipram/roflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer's disease., 163 [PMID:30553143] [10.1016/j.ejmech.2018.12.013] |
| 215. Di Pietro O, Alencar N, Esteban G, Viayna E, Szałaj N, Vázquez J, Juárez-Jiménez J, Sola I, Pérez B, Solé M, Unzeta M, Muñoz-Torrero D, Luque FJ.. (2016) Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors., 24 (20): [PMID:27396685] [10.1016/j.bmc.2016.06.045] |
| 216. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 217. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 218. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 219. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 220. Johannes Zuegg, Alysha Elliott, Maite Amado, Emma Cowie, Ali Hinton, Geraldine Kaeslin, Angela Kavanagh, Anne Kunert, Gabriell Lowe, Soumya Ramu, Janet Reid, Robin Trauer, Mathilde Desselle, Ruth Neale, Karl Hansford, Mark Blascovich, Matthew Cooper. CO-ADD screening of NIH (USA) - Clinical Collection, [10.6019/CHEMBL4513141] |
| 221. Li Q, Xing S, Chen Y, Liao Q, Xiong B, He S, Lu W, Liu Y, Yang H, Li Q, Feng F, Liu W, Chen Y, Sun H.. (2020) Discovery and Biological Evaluation of a Novel Highly Potent Selective Butyrylcholinsterase Inhibitor., 63 (17): [PMID:32787113] [10.1021/acs.jmedchem.0c01129] |
| 222. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
| 223. Pellicciari R,Passeri D,De Franco F,Mostarda S,Filipponi P,Colliva C,Gadaleta RM,Franco P,Carotti A,Macchiarulo A,Roda A,Moschetta A,Gioiello A. (2016) Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders., 59 (19): [PMID:27652492] [10.1021/acs.jmedchem.6b01126] |
| 224. Jiang X,Wang Y,Liu C,Xing C,Wang Y,Lyu W,Wang S,Li Q,Chen T,Chen Y,Feng F,Liu W,Sun H. (2021) Discovery of potent glycogen synthase kinase 3/cholinesterase inhibitors with neuroprotection as potential therapeutic agent for Alzheimer's disease., 30 [PMID:33340937] [10.1016/j.bmc.2020.115940] |
| 225. Jiang X,Zhou J,Wang Y,Chen L,Duan Y,Huang J,Liu C,Chen Y,Liu W,Sun H,Feng F,Qu W. (2020) Rational design and biological evaluation of a new class of thiazolopyridyl tetrahydroacridines as cholinesterase and GSK-3 dual inhibitors for Alzheimer's disease., 207 [PMID:32950908] [10.1016/j.ejmech.2020.112751] |
| 226. Salgin-Goksen U,Telli G,Erikci A,Dedecengiz E,Tel BC,Kaynak FB,Yelekci K,Ucar G,Gokhan-Kelekci N. (2021) New 2-Pyrazoline and Hydrazone Derivatives as Potent and Selective Monoamine Oxidase A Inhibitors., 64 (4.0): [PMID:33533632] [10.1021/acs.jmedchem.0c01504] |
| 227. Massari S,Bertagnin C,Pismataro MC,Donnadio A,Nannetti G,Felicetti T,Di Bona S,Nizi MG,Tensi L,Manfroni G,Loza MI,Sabatini S,Cecchetti V,Brea J,Goracci L,Loregian A,Tabarrini O. (2021) Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase., 209 [PMID:33328103] [10.1016/j.ejmech.2020.112944] |
| 228. Zhang Z,Guo J,Cheng M,Zhou W,Wan Y,Wang R,Fang Y,Jin Y,Liu J,Xie SS. (2021) Design, synthesis, and biological evaluation of novel xanthone-alkylbenzylamine hybrids as multifunctional agents for the treatment of Alzheimer's disease., 213 [PMID:33476932] [10.1016/j.ejmech.2021.113154] |
| 229. Xie SS,Liu J,Tang C,Pang C,Li Q,Qin Y,Nong X,Zhang Z,Guo J,Cheng M,Tang W,Liang N,Jiang N. (2020) Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease., 202 [PMID:32652406] [10.1016/j.ejmech.2020.112475] |
| 230. Liu W, Liu X, Tian L, Gao Y, Liu W, Chen H, Jiang X, Xu Z, Ding H, Zhao Q.. (2021) Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease., 222 [PMID:34098466] [10.1016/j.ejmech.2021.113554] |
| 231. Jiang X, Zhang Z, Zuo J, Wu C, Zha L, Xu Y, Wang S, Shi J, Liu XH, Zhang J, Tang W.. (2021) Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease., 223 [PMID:34371367] [10.1016/j.ejmech.2021.113735] |
| 232. Li K, Diakite D, Austin J, Lee JH, Lantvit DD, Murphy BT, Burdette JE.. (2022) The Flavonoid Baicalein Negatively Regulates Progesterone Target Genes in the Uterus in Vivo., 85 (1.0): [PMID:34935393] [10.1021/acs.jnatprod.1c01008] |
| 233. Kurohara T, Ito T, Tsuji G, Misawa T, Yokoo H, Yanase Y, Shoda T, Sakai T, Hosoe J, Uchiyama N, Akiyama H, Demizu Y.. (2021) Synthesis of Norgestomet and its 17β-isomer and evaluation of their agonistic activities against progesterone receptor., 49 [PMID:34607200] [10.1016/j.bmc.2021.116425] |
| 234. Xi M, Feng C, Du K, Lv W, Du C, Shen R, Sun H.. (2022) Design, synthesis, biological evaluation and molecular modeling of N-isobutyl-N-((2-(p-tolyloxymethyl)thiazol-4yl)methyl)benzo[d][1,3] dioxole-5-carboxamides as selective butyrylcholinesterase inhibitors., 61 [PMID:35124202] [10.1016/j.bmcl.2022.128602] |
| 235. Jaiswal S, Akhilesh, Uniyal A, Tiwari V, Raja Ayyannan S.. (2022) Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and antinociceptive activities of 4-methylsulfonylaniline-derived semicarbazones., 60 [PMID:35296453] [10.1016/j.bmc.2022.116698] |
| 236. Turcu AL, Companys-Alemany J, Phillips MB, Patel DS, Griñán-Ferré C, Loza MI, Brea JM, Pérez B, Soto D, Sureda FX, Kurnikova MG, Johnson JW, Pallàs M, Vázquez S.. (2022) Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease., 236 [PMID:35453065] [10.1016/j.ejmech.2022.114354] |
| 237. Liu P, Cheng M, Guo J, Cao D, Luo J, Wan Y, Fang Y, Jin Y, Xie SS, Liu J.. (2023) Dual functional antioxidant and butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease: Design, synthesis and evaluation of novel melatonin-alkylbenzylamine hybrids., 78 [PMID:36580744] [10.1016/j.bmc.2022.117146] |
| 238. Shim S, Jeong DU, Kim H, Kim CY, Park H, Jin Y, Kim KM, Lee HJ, Kim DH, Bae YS, Choi Y.. (2022) Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson's disease., 244 [PMID:36274279] [10.1016/j.ejmech.2022.114854] |
| 239. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |
